News | Molecular Imaging | July 16, 2015

Trio of European Health Centers Upgrading to Elekta's Leksell Gamma Knife Icon

System integrates advanced motion management, dose delivery and imaging technologies for cranial radiosurgery

Elekta, Leksell Gamma Knife Icon, European health centers, upgrade

July 16, 2015 -- Three foremost medical centers in the United Kingdom and Germany have ordered and are now planning upgrades to Elekta's latest generation stereotactic radiosurgery system for the brain, Leksell Gamma Knife Icon. The centers are: University Medical Centre Mannheim (UMC, Mannheim, Germany); Bristol Gamma Knife Centre, University Hospitals Bristol NHS Foundation Trust (Bristol, U.K.); and The Leeds Gamma Knife Centre at St James's Institute of Oncology (Leeds, U.K.).

Leksell Gamma Knife Icon integrates advanced motion management, dose delivery and imaging technologies, enabling clinicians to treat a wider variety of tumor types and sizes. The system provides caregivers increased flexibility in how radiosurgery is delivered, by allowing doctors to choose either frame-based or frameless methods to immobilize the patient's head, in addition to the option to perform the treatment in a single session or multiple sessions. Icon also permits physicians to choose the degree of precision needed for each patient case - ranging from traditional high radiosurgery accuracy to ultra-precise microradiosurgery.

The ability to deliver multi-fraction Gamma Knife radiosurgery to spare organs-at-risk was important to clinicians at University Medical Centre Mannheim, according to Frederik Wenz, M.D., professor and chairman, Department of Radiation Oncology at UMC.

"The steep dose gradients and mechanical stability offered by Gamma Knife Icon allow sparing of normal tissue adjacent to the target," he said. "In clinical situations with sensitive structures within the target volume, sparing of organs-at-risk can only be achieved by fractionation [i.e., multiple sessions]. By fractionating the dose, we can use Icon in many clinical scenarios in which the tumor is infiltrating normal tissue."

Wenz anticipates treating the first patients with Gamma Knife Icon in late August.

Alison Cameron, M.D., clinical lead for the Bristol Gamma Knife, said: "Icon will allow Bristol to offer an intracranial stereotactic service without any compromises. The system has the flexibility to ensure that the patient receives the level of radiosurgery that they require clinically, whilst optimizing their experience through flexibility in immobilization, scheduling and treatment. This will lead to increased efficiency with improved quality, a truly transformational service development."

The team in Bristol expect to treat the first patient in September.

At The Leeds Gamma Knife Centre, Paul Hatfield, M.D., consultant clinical oncologist, observes that the frameless immobilization and accurate intrafraction monitoring of patient position are particularly valuable features of Icon.

"These features will enable fractionated treatment for targets that would normally be too large to treat, or where dose reductions would typically be required, for safety reasons, that could potentially compromise treatment effect," Hatfield said. "The cone beam CT [computed tomography] also will allow confirmation of setup, which is an important part of modern radiotherapy. All of these benefits combined will undoubtedly enhance the patient experience."

The Gamma Knife Icon system is expected to be operational at The Leeds Gamma Knife Centre by the end of 2015.

For more information: www.elekta.com

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init